News & Updates

A team of Singapore-based researchers has identified two blood biomarkers that not only predict clinical response to immune checkpoint inhibitors (ICIs) in hepatocellular carcinoma (HCC) patients but also the incidence of side effects from the same treatment.

Patients who take multivitamin supplements at a moderate dose following their diagnosis of nonmetastatic colorectal cancer (CRC) appear to have a lower mortality, reports a recent study.

Prostate cancer (PCa) patients with higher lymph node (LN) risk scores and Gleason grade who are treated with whole pelvis radiotherapy (WPRT) have better overall survival (OS), reports a study.

Men with prostate cancer have about a 50-percent increased risk of developing venous thromboembolism, a study has found.

Accelerated administration of daratumumab, an anti-CD3 monoclonal antibody approved for multiple myeloma, is safe and well tolerated when given following at least two standard infusions, suggest the results of a recent study.